Cargando…

Low dose versus standard dose rituximab for the treatment of antiphospholipid syndrome: A pilot study from a tertiary medical center

BACKGROUND: To investigate the therapeutic effects and safety of low-dose and standard-dose rituximab (RTX) in the treatment of antiphospholipid syndrome (APS). METHODS: In this real-world study, we included 22 consecutive patients with APS who received RTX. Standard dose (SD) was defined as an over...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gan, Yuzhou, Zhong, Xue, Zhao, Yawei, Li, Gongming, Ye, Hua, Li, Chun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670802/ https://www.ncbi.nlm.nih.gov/pubmed/36405743 http://dx.doi.org/10.3389/fimmu.2022.971366

Ejemplares similares

Risk Factors and Outcomes of Acute Myocardial Infarction in a Cohort of Antiphospholipid Syndrome
por: Gan, Yuzhou, et al.
Publicado: (2022)

Sirolimus Monotherapy for Thrombocytopenia in Primary Antiphospholipid Syndrome: A Pilot Study From a Tertiary Referral Center
por: Xie, Wenhui, et al.
Publicado: (2022)

A novel aGAPSS-based nomogram for the prediction of ischemic stroke in patients with antiphospholipid syndrome
por: Song, Xiaodong, et al.
Publicado: (2022)

The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
por: Youkhana, Kimberley, et al.
Publicado: (2023)

Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody
por: Hou, Ying, et al.
Publicado: (2022)

Non-criteria antiphospholipid antibodies in antiphospholipid syndrome: Diagnostic value added
por: Liu, Xiangjun, et al.
Publicado: (2022)

An update on the biologics for the treatment of antiphospholipid syndrome
por: Yun, Zelin, et al.
Publicado: (2023)

Modifications of the BAFF/BAFF-Receptor Axis in Patients With Pemphigus Treated With Rituximab Versus Standard Corticosteroid Regimen
por: Hébert, Vivien, et al.
Publicado: (2021)

Prevalence and diagnostic value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome in Chinese patients
por: Li, Siting, et al.
Publicado: (2023)

Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome
por: Jin, Jiayang, et al.
Publicado: (2022)

Antiphospholipid Antibodies and Antiphospholipid Syndrome during Pregnancy: Diagnostic Concepts
por: Levy, Roger A., et al.
Publicado: (2015)

Rituximab at lower dose for neuromyelitis optica spectrum disorder: a multicenter, open-label, self-controlled, prospective follow-up study
por: Zhao, Daidi, et al.
Publicado: (2023)

Prevalence, risk factors, and prognosis of central nervous system manifestations in antiphospholipid syndrome
por: Liu, Meige, et al.
Publicado: (2023)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome
por: Zhou, Zhuochao, et al.
Publicado: (2021)

Comparison of non-criteria antiphospholipid syndrome with definite antiphospholipid syndrome: A systematic review
por: Pires da Rosa, Gilberto, et al.
Publicado: (2022)

Renal Involvement in Antiphospholipid Syndrome
por: Turrent-Carriles, Alonso, et al.
Publicado: (2018)

Complement in the Pathophysiology of the Antiphospholipid Syndrome
por: Chaturvedi, Shruti, et al.
Publicado: (2019)

Editorial: Primary Antiphospholipid Syndrome
por: Serrano, Antonio, et al.
Publicado: (2020)

Case Report: High Doses of Intravenous Immunoglobulins as a Successful Treatment for Late Onset Immune Agranulocytosis After Rituximab Plus Bendamustine
por: Diez-Feijóo, Ramon, et al.
Publicado: (2022)

Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome
por: Tan, Yuan, et al.
Publicado: (2023)

The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome
por: Sayar, Zara, et al.
Publicado: (2022)

The role of the intestinal microbiome in antiphospholipid syndrome
por: van Mourik, Dagmar J. M., et al.
Publicado: (2022)

Hemorrhage complications in obstetric antiphospholipid syndrome: Risk factors and association with adverse pregnancy outcomes
por: Luo, Yongjing, et al.
Publicado: (2023)

Single, very low rituximab doses in healthy volunteers - a pilot and a randomized trial: implications for dosing and biosimilarity testing
por: Schoergenhofer, Christian, et al.
Publicado: (2018)

Antiphospholipid Syndrome Nephropathy: From Pathogenesis to Treatment
por: Tektonidou, Maria G.
Publicado: (2018)

Editorial: Systemic Lupus Erythematosus and Antiphospholipid Syndrome
por: Meroni, Pier Luigi, et al.
Publicado: (2019)

Exosome-Contained APOH Associated With Antiphospholipid Syndrome
por: Tan, Yuan, et al.
Publicado: (2021)

Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
por: Li, Xueying, et al.
Publicado: (2019)

Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
por: Bagchi, Soumita, et al.
Publicado: (2018)

Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL)
por: Savelli, Stephanie L., et al.
Publicado: (2019)

Eliciting Dose and Safety Outcomes From a Large Dataset of Standardized Multiple Food Challenges
por: Purington, Natasha, et al.
Publicado: (2018)

Neutralizing Anti-Rituximab Antibodies and Relapse in Membranous Nephropathy Treated With Rituximab
por: Boyer-Suavet, Sonia, et al.
Publicado: (2020)

Preliminary Study on the Imbalance Between Th17 and Regulatory T Cells in Antiphospholipid Syndrome
por: Yan, Huanhuan, et al.
Publicado: (2022)

Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018)

Restriction of the Global IgM Repertoire in Antiphospholipid Syndrome
por: Pashova, Shina, et al.
Publicado: (2022)

Antiphospholipid Antibodies and Infection: Non Nova Sed Nove
por: Sciascia, Savino, et al.
Publicado: (2021)

Single-dose Rituximab Therapy for Refractory Idiopathic Membranous Nephropathy: A Single-center Experience
por: Katsuno, Takayuki, et al.
Publicado: (2017)

Comparison of Different Test Systems for the Detection of Antiphospholipid Antibodies in a Chinese Cohort
por: Hu, Chaojun, et al.
Publicado: (2021)

Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis
por: Gratacós, Jordi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dcfjg4bpmh5qr0di6v0lqngvcs